New Zealand Anti-Smoking Group Threatens E-Cigarettes

Dec.09.2022
New Zealand Anti-Smoking Group Threatens E-Cigarettes
ARFNZ threatens e-cigarettes, but CAPHRA says they should focus on reducing harm from combustible tobacco instead.

The Asthma and Respiratory Foundation New Zealand (ARFNZ) has carried out a scare campaign against electronic cigarettes. The Asia Pacific advocates for reducing tobacco harm (CAPHRA) described it as a "very tiresome" move.


Nancy Loucas, the coordinator of the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), expressed disappointment with the recent actions of the New Zealand Asthma and Respiratory Foundation against the Ministry of Health. Loucas lamented that this behavior was not surprising.


After she made her comments, ARFNZ claimed that the Ministry of Health had not achieved an appropriate balance with New Zealand's electronic cigarette regulations.


The ARFNZ's ongoing scare tactics against e-cigarettes are often unfounded. The reality is that New Zealand has successfully implemented a strategy to reduce the harm of tobacco (THR) and is on track to becoming smoke-free by 2025. According to Ms. Loucas, the attacks from ARFNZ should be directed towards combustible cigarettes.


CAPHRA was shocked to learn from the latest official statistics that ARFNZ is continuing on its path of new prohibitionism. Earlier this month, it was revealed that New Zealand's smoking rate has dropped to its lowest point in history, with only 8% of adults smoking daily, down from 9.4% a year ago.


The smoke-free environment and regulated products (tobacco) amendment is currently being passed through parliament. It aims to restrict the appeal and accessibility of cigarettes.


The Smoke-free Amendment Bill is what ARFNZ should be focusing on entirely at present. However, they seem determined to continually undermine and criticize the Ministry of Health's position on e-cigarettes. The issue is not about the need for safer nicotine alternatives to cigarettes, which could save the lives of thousands of New Zealand smokers every year," Ms. Loucas stated.


CAPHRA has stated that many other countries are studying and replicating New Zealand's smoke-free policies. Recently, a Malaysian parliamentary delegation visited New Zealand to learn how they halved smoking rates in the past decade. New Zealand's regulatory framework is also crucial to recent regulations in the Philippines, and even Thailand is considering developing their own regulations based on New Zealand's.


2FIRSTS will continue to follow and report on this issue. Updates will be available on the "2FIRSTSAPP". Scan the QR code below to download the app.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris Says Its Smoke-Free Transition in Spain Now Has Economic Impact Above EUR 3.3 Billion
Philip Morris said it is accelerating its transition toward smoke-free products in Spain and claimed that the related economic impact now exceeds EUR 3.3 billion. Philip Morris also said that more than 90% of nicotine consumption in Spain still comes from conventional cigarettes, leaving room for growth in smoke-free categories, while regulation and taxation remain major obstacles in its view.
Apr.21 by 2FIRSTS.ai
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s DDC Reaffirms Nicotine Pouches Are Regulated Under the Tobacco Products Control Act
Thailand’s Department of Disease Control has warned the public not to believe claims that nicotine pouches are harmless, saying the products contain high levels of nicotine that can enter the bloodstream through the mouth lining and affect the nervous system and brain.
Apr.30 by 2FIRSTS.ai
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Tobacco Center Plans Faster Review Process for Certain Supplemental PMTAs
FDA Center for Tobacco Products Acting Director Bret Koplow issued a statement on May 7 outlining new steps to accelerate tobacco product premarket application review. The statement said CTP reduced the backlog of applications by approximately 70% in 2025 and that there is no longer a queue for PMTAs pending acceptance review.
May.09 by 2FIRSTS.ai
PML Expands Its UK Smoke-Free Portfolio With LEVIA
PML Expands Its UK Smoke-Free Portfolio With LEVIA
Philip Morris Limited has launched LEVIA, a new range of zero-tobacco flavored nicotine sticks created for the IQOS ILUMA range. The product expands the company’s smoke-free portfolio in the UK and will initially be available in four variants, including Deep Mint and three capsule-based flavors. LEVIA has a recommended retail price of £5, or about $6.73, based on the European Central Bank’s April 28.
Apr.29 by 2FIRSTS.ai